World Journal of
Pharmaceutical and Life Sciences

AN EFFECTIVE MANAGEMENT OF ANANTAVATA WITH SPECIAL REFERENCE TO TRIGEMINAL NEURALGIA: A CASE STUDY

*Dr. Shashirekha S. D., Dr. Shilpa S., Dr. Shubha Hegde

ABSTRACT

Trigeminal neuralgia (TN) is a neuropathic disorder marked by sudden, intense, stabbing pain in the lower face and jaw, typically affecting one side of the face and often triggered by simple activities like touching the face, brushing teeth, or exposure to cold wind.[1] The pain follows the distribution of the trigeminal nerve (CN V), which innervates the forehead, cheek, and lower jaw.[1] Globally, TN has an annual incidence of approximately 4–8 cases per 100,000 individuals, with a higher prevalence among women (about 5.9 cases per 100,000) compared to men (3.4 cases per 100,000).[1] Bilateral involvement is rare, occurring in only about 3% of cases.[1] Risk factors include multiple sclerosis, hypertension, and herpes zoster, and in most cases, the pain is due to compression of the trigeminal nerve by vascular structures.[1]

[Full Text Article]   [Download Certificate]